"sell" rating on the stock, while the number of analysts with a "hold" and "buy" recommendation on Asian Paints stood at 11 ...

Pharmaceuticals stock, reducing the price target from $1,185.00 to $1,150.00. Despite the decrease, the firm maintained its Overweight rating on the NASDAQ-listed company. According to InvestingPro ...

Morgan Stanley (NYSE:MS) revised its expectations for Federal Reserve rate cuts in 2025, now anticipating only one reduction ...

Morgan Stanley Wealth Management (MSWM) is seeing a stall in the S&P 500 ( SP500 ), and said the Federal Reserve halting its ...

A group of Morgan Stanley-led banks is set to increase a sale of loans tied to Elon Musk's social media platform X after ...

Fresh off of his stellar year in 2024, Dennis Lynch is Business Insider's Investor of the Month for January.

Tech stocks rally as Palantir jumps 26%, lifting Nasdaq 100. Apple may hike iPhone prices due to tariffs. Earnings drive ...

The S&P 500 will trade in a range that implies the index dropping as much as 8% or rising a little over 1% in the coming ...

A Wall Street analyst sees more upside for Nvidia (NASDAQ: NVDA) stock despite the equity facing uncertainty amid escalating ...

Morgan Stanley has finally conceded that Palantir Technologies is not a stock to sell, but its analysts aren't quite ready to ...

Palantir has seen a remarkable surge following its latest earnings report, closing Monday at $83.74, up 1.52% for the day.

Investors got another taste of volatility as President Donald Trump's planned tariffs on imports from Canada, Mexico and ...